COVID-19 studies are our top priority.

For new and updated trial submissions, we are processing trials as quickly as possible and appreciate your patience. We recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR

Registration number
Ethics application status
Date submitted
Date registered
Date last updated
Date data sharing statement initially provided
Date results information initially provided
Type of registration
Prospectively registered

Titles & IDs
Public title
Haem-Fit: Exercise and Wellness Program for Haematology Cancer patients
Scientific title
Haem-Fit: A 3 month intervention trial to assess patient adherence and maintenance of muscle mass by implementing an exercise and wellness program for haematology cancer patients in hospital for 7 days or more
Secondary ID [1] 293817 0
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
haematological cancers 306232 0
physical deconditioning 306233 0
stress and anxiety 306235 0
physical inactivity 306236 0
loss of muscle mass 306237 0
Condition category
Condition code
Cancer 305335 305335 0 0
Leukaemia - Acute leukaemia
Cancer 305336 305336 0 0
Leukaemia - Chronic leukaemia
Cancer 305337 305337 0 0
Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma
Cancer 305338 305338 0 0
Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma
Cancer 305426 305426 0 0
Cancer 305427 305427 0 0
Other cancer types

Study type
Description of intervention(s) / exposure
Each participant will be assessed by a physiotherapist (face to face) and provided with an exercise program. This initial assessment will take approximately 30-60 minutes depending on patient needs, but it will not be time restricted. Each patient will be provided with an exercise routine of 10-15 minutes duration that combines simple exercises for maintaining strength and balance and is tailored to their personal fitness levels and health circumstances.. They will be expected to perform the routine at least once per day, plus additional time (at least 10 minutes) walking. The level of intensity should be about 3-4 (slight shortness of breath) on the 10 point modified Borg Scale. Tailored exercises will be necessary to account for patients with central or PICC lines, receiving chemotherapy, or suffering low blood counts. Five different alternating exercises will be prescribed to be preformed at least once daily while in hospital. Ward nurses will be trained to assist with monitoring correct performance of the exercises. Subsequent referral to a physiotherapist can be made at any time as per normal standard of care. Each participant will also be given written information on diet, nutrition, and exercise. These resources have been specifically designed for the study and will not be made available to non-study participants. Participants will be asked to keep a diary to assess adherence.
Intervention code [1] 300083 0
Intervention code [2] 300084 0
Intervention code [3] 300085 0
Comparator / control treatment
A survey of haematology in-patients was conducted at the Calvary Mater Newcastle in NSW over a 12 week period from Aug – Oct, 2017. All patients admitted with a haematological malignancy and an anticipated length of stay of at least 7 days were eligible. 19 participants were recruited and completed impedance measurements using InBody570, Hospital and Anxiety Depression Scale and a Quality of Life Questionnaire survey on admission and discharge. All participants received current standard of care without addition of a structured exercise program.
Control group

Primary outcome [1] 304498 0
Rate of patient adherence (patient diaries)
% of exercises attempted (out of 5 per day x days in hospital) and number of days exercised (out of total in hospital days)
Timepoint [1] 304498 0
at discharge
Primary outcome [2] 304499 0
change in muscle mass using impedance measurement (InBody570)
Timepoint [2] 304499 0
at discharge
Secondary outcome [1] 342157 0
patient satisfaction by phone interview. Participants will be asked a series of 12 yes/no questions and encouraged to give additional feedback on why/why not.
Timepoint [1] 342157 0
1 week post discharge
Secondary outcome [2] 342389 0
staff satisfaction by paper questionnaire which was designed specifically for this study. Staff will be given a set of 10 statements and asked to rate their agreement from 1-5 with 1 being 'strongly agree' and 5 being 'strongly disagree'.
Timepoint [2] 342389 0
end of accrual

Key inclusion criteria
all hematology cancer patient admissions with 7 or more days anticipated length of stay
Minimum age
18 Years
Maximum age
No limit
Both males and females
Can healthy volunteers participate?
Key exclusion criteria
• People with artificial electrical implants such as a defibrillator or pacemaker will be excluded due to inability to undergo impedance bodycomposition testing
• Inability to communicate in English

Study design
Purpose of the study
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?

Intervention assignment
Single group
Other design features
Not Applicable
Type of endpoint(s)
Statistical methods / analysis

Recruitment status
Date of first participant enrolment
Date of last participant enrolment
Date of last data collection
Sample size
Accrual to date
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 9835 0
Calvary Mater Newcastle - Waratah
Recruitment postcode(s) [1] 18613 0
2298 - Waratah

Funding & Sponsors
Funding source category [1] 298431 0
Name [1] 298431 0
Hunter Cancer Research Alliance
Address [1] 298431 0
University of Newcastle, University Drive, Callaghan, NSW 2308 (HMRI Building, L3W)
Country [1] 298431 0
Primary sponsor type
Calvary MAter Newcastle Hunter Haematology Unit
Calvary Mater Newcastle
Edith St
NSW 2298
Secondary sponsor category [1] 297573 0
Name [1] 297573 0
Calvary Mater Newcastle Physiotherapy department
Address [1] 297573 0
Calvary Mater Newcastle
Edith St
NSW 2298
Country [1] 297573 0

Ethics approval
Ethics application status
Ethics committee name [1] 299427 0
Hunter New England Human Research Ethics Committee
Ethics committee address [1] 299427 0
Governance Research Ethics and Governance Office
Locked bag 1, New Lambton, NSW, 2305
Ethics committee country [1] 299427 0
Date submitted for ethics approval [1] 299427 0
Approval date [1] 299427 0
Ethics approval number [1] 299427 0

Brief summary
The purpose of this research is to test an exercise and wellness program for haematology in-patients receiving cancer treatment.

Who is it for?
You may be eligible for this study if you are undergoing treatment for a haematological malignancy at the Calvary Mater Newcastle Hospital which requires you to be in hospital for at least 7 days.

Study details
Each participant will be assessed by a physiotherapist (face to face) and provided with a personalised exercise program (30-60 minutes duration of strength and balance + walking) tailored to be performed daily while in hospital. Each participant will also be given written information on diet, nutrition, and exercise.

This study will help to determine adherence and satisfaction of patients and staff to a personalised exercise program while in hospital.
Trial website
Trial related presentations / publications
Public notes
Attachments [1] 2409 2409 0 0
Attachments [2] 2410 2410 0 0

Principal investigator
Name 80366 0
Prof Philip Rowlings
Address 80366 0
Hunter Haematology Unit
Calvary Mater Newcastle
Edith St
NSW 2298
Country 80366 0
Phone 80366 0
+61 2 40143027
Fax 80366 0
+61 2 49602136
Email 80366 0
Contact person for public queries
Name 80367 0
Ms Casey Hutchinson
Address 80367 0
Hunter Haematology Unit
Calvary Mater Newcastle
Edith St
NSW 2298
Country 80367 0
Phone 80367 0
+61 2 40143087
Fax 80367 0
+61 2 49602136
Email 80367 0
Contact person for scientific queries
Name 80368 0
A/Prof Lisa Lincz
Address 80368 0
Hunter Haematology Research Group
Calvary Mater Newcastle
Edith St
NSW 2298
Country 80368 0
Phone 80368 0
+61 2 40143049
Fax 80368 0
+61 2 49602136
Email 80368 0

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No/undecided IPD sharing reason/comment
What supporting documents are/will be available?
Study protocol
Informed consent form
Ethical approval
How or where can supporting documents be obtained?
Type [1] 6625 0
Informed consent form
Citation [1] 6625 0
Link [1] 6625 0
Email [1] 6625 0
Other [1] 6625 0
Type [2] 6626 0
Ethical approval
Citation [2] 6626 0
Link [2] 6626 0
Email [2] 6626 0
Other [2] 6626 0
Type [3] 6627 0
Study protocol
Citation [3] 6627 0
Link [3] 6627 0
Email [3] 6627 0
Other [3] 6627 0
Attachment [3] 6627 0
Summary results
Have study results been published in a peer-reviewed journal?
Other publications
Have study results been made publicly available in another format?
Results – basic reporting
Results – plain English summary